AAV vectors: The Rubik’s cube of human gene therapy

遗传增强 转导(生物物理学) 腺相关病毒 基因传递 向性 生物 载体(分子生物学) 衣壳 免疫系统 组织向性 基因 计算生物学 病毒载体 病毒学 基因治疗载体 病毒 生物信息学 重组DNA 遗传学 生物化学
作者
Amaury Pupo,Audry Fernández,Siew Hui Low,Achille François,Lester Suárez-Amarán,R. Jude Samulski
出处
期刊:Molecular Therapy [Elsevier BV]
卷期号:30 (12): 3515-3541 被引量:244
标识
DOI:10.1016/j.ymthe.2022.09.015
摘要

Defective genes account for ∼80% of the total of more than 7,000 diseases known to date. Gene therapy brings the promise of a one-time treatment option that will fix the errors in patient genetic coding. Recombinant viruses are highly efficient vehicles for in vivo gene delivery. Adeno-associated virus (AAV) vectors offer unique advantages, such as tissue tropism, specificity in transduction, eliciting of a relatively low immune responses, no incorporation into the host chromosome, and long-lasting delivered gene expression, making them the most popular viral gene delivery system in clinical trials, with three AAV-based gene therapy drugs already approved by the US Food and Drug Administration (FDA) or European Medicines Agency (EMA). Despite the success of AAV vectors, their usage in particular scenarios is still limited due to remaining challenges, such as poor transduction efficiency in certain tissues, low organ specificity, pre-existing humoral immunity to AAV capsids, and vector dose-dependent toxicity in patients. In the present review, we address the different approaches to improve AAV vectors for gene therapy with a focus on AAV capsid selection and engineering, strategies to overcome anti-AAV immune response, and vector genome design, ending with a glimpse at vector production methods and the current state of recombinant AAV (rAAV) at the clinical level. Defective genes account for ∼80% of the total of more than 7,000 diseases known to date. Gene therapy brings the promise of a one-time treatment option that will fix the errors in patient genetic coding. Recombinant viruses are highly efficient vehicles for in vivo gene delivery. Adeno-associated virus (AAV) vectors offer unique advantages, such as tissue tropism, specificity in transduction, eliciting of a relatively low immune responses, no incorporation into the host chromosome, and long-lasting delivered gene expression, making them the most popular viral gene delivery system in clinical trials, with three AAV-based gene therapy drugs already approved by the US Food and Drug Administration (FDA) or European Medicines Agency (EMA). Despite the success of AAV vectors, their usage in particular scenarios is still limited due to remaining challenges, such as poor transduction efficiency in certain tissues, low organ specificity, pre-existing humoral immunity to AAV capsids, and vector dose-dependent toxicity in patients. In the present review, we address the different approaches to improve AAV vectors for gene therapy with a focus on AAV capsid selection and engineering, strategies to overcome anti-AAV immune response, and vector genome design, ending with a glimpse at vector production methods and the current state of recombinant AAV (rAAV) at the clinical level.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xiaobai发布了新的文献求助10
刚刚
西红柿完成签到,获得积分10
刚刚
大模型的应助被开朗紫采纳,获得10
刚刚
研友_ndvWy8完成签到,获得积分10
1秒前
2秒前
3秒前
4秒前
莓莓发布了新的文献求助10
5秒前
FG完成签到,获得积分10
5秒前
爆米花的应助被简单山水采纳,获得10
5秒前
上官若男的应助被雾潋采纳,获得10
6秒前
Kiss完成签到,获得积分10
8秒前
cdercder的应助被fzt采纳,获得10
8秒前
8秒前
GBY完成签到,获得积分10
9秒前
LIUJIAWEI发布了新的文献求助10
10秒前
Maestro_S的应助被一呆采纳,获得10
10秒前
GBY发布了新的文献求助10
11秒前
BINBIN完成签到,获得积分10
13秒前
顺利的盼曼完成签到 ,获得积分10
14秒前
我的djwhjja发布了新的文献求助10
14秒前
1234完成签到,获得积分10
16秒前
creach完成签到,获得积分10
16秒前
科研通AI6.3的应助被WZJ采纳,获得10
17秒前
悦耳凤灵完成签到,获得积分10
18秒前
Jasper的应助被李飞龙采纳,获得10
18秒前
领导范儿的应助被xiaobai采纳,获得10
21秒前
Jun的应助被GBY采纳,获得10
21秒前
21秒前
22秒前
我的djwhjja完成签到,获得积分10
22秒前
22秒前
光亮发卡发布了新的文献求助10
22秒前
李健的小迷弟的应助被yosh采纳,获得10
22秒前
creach发布了新的文献求助10
23秒前
pp完成签到,获得积分10
23秒前
23秒前
不爱喝酒的应助被interest-li采纳,获得10
24秒前
852的应助被wwwwwl采纳,获得30
24秒前
Owen的应助被interest-li采纳,获得10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181658
求助须知:如何正确求助?哪些是违规求助? 9571454
关于积分的说明 21818081
捐赠科研通 7777987
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479568